Evidence map›Paper›PMID 34267605›Full record

ArticlePathology oncology research : POR2021

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant

Jewel Ju Ea Kim, Ildikó Kocsmár, György Miklós Buzás, Ildikó Szirtes, Orsolya Rusz, Csaba Diczházi, Attila Szijártó, István Hritz, Zsuzsa Schaff, András Kiss and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Involvement ofInternational journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jewel Ju Ea Kim2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Ildikó Kocsmár2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
György Miklós BuzásDepartment of Gastroenterology, Ferencváros Health Centre, Budapest, Hungary.
Ildikó SzirtesDepartment of Pharmacy, Péterfy Hospital - National Institute of Traumatology, Budapest, Hungary.
Orsolya Rusz2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Csaba DiczháziDepartment of Pathology, Péterfy Hospital - National Institute of Traumatology, Budapest, Hungary.
Attila Szijártó1st Department of Surgery and Interventional Gastroenterology, Semmelweis University, Budapest, Hungary.
István Hritz1st Department of Surgery and Interventional Gastroenterology, Semmelweis University, Budapest, Hungary.
Zsuzsa Schaff2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
András Kiss2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Éva Kocsmár2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Gábor Lotz2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of

Indexed as

Bacterial LoadDrug Resistance, BacterialAnti-Bacterial AgentsClarithromycinCross-Sectional StudiesFemaleFollow-Up StudiesHelicobacter InfectionsHelicobacter pyloriHumansMaleMiddle AgedPrognosisRetrospective StudiesAnti-Bacterial AgentsClarithromycinantibiotic resistancebacterial densityclarithromycinfluorescence in situ hybridizationHelicobacter pyloriheteroresistance

Identifiers

PMID34267605
PMCPMC8275651
OpenAlexW3173892059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.